Pieris Pharmaceuticals Inc (PIRS)
13.60
-2.53
(-15.69%)
USD |
NASDAQ |
Dec 13, 16:00
13.35
-0.25
(-1.84%)
After-Hours: 20:00
Pieris Pharmaceuticals Research and Development Expense (Quarterly): -0.446M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 5.675M |
| Cyclo Therapeutics Inc | 5.493M |
| NovaBay Pharmaceuticals Inc | 0.004M |
| Palatin Technologies Inc | 5.744M |
| iBio Inc | 1.305M |